Insys Therapeutics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2005
2006
2007
2008
2009
Net Income before Extraordinaries
38,724.70
33,208.00
11,001.00
8,218.00
7,461.00
Depreciation, Depletion & Amortization
1,299.90
1,153.00
651.00
174.00
135.00
Other Funds
0.00
0.00
0.00
0.00
0.00
Funds from Operations
36,631.80
31,442.00
12,071.00
7,548.00
6,333.00
Changes in Working Capital
2,825.70
260.00
5,909.00
220.00
1,367.00
Net Operating Cash Flow
33,806.00
31,182.00
17,980.00
7,768.00
7,700.00
Capital Expenditures
587.70
204.00
89.00
145.00
19.00
Sale of Fixed Assets & Businesses
0.00
0.00
303.00
19.00
0.00
Purchase/Sale of Investments
18,350.00
7,950.00
16,950.00
5,003.00
750.00
Net Investing Cash Flow
18,937.70
8,154.00
17,164.00
4,877.00
731.00
Cash Dividends Paid - Total
0.00
0.00
0.00
0.00
0.00
Issuance/Reduction of Debt, Net
0.00
26.00
30.00
9,164.00
4,713.00
Net Financing Cash Flow
1,493.50
39,702.00
14.00
9,167.00
4,713.00
Net Change in Cash
51,250.10
366.00
830.00
6,276.00
2,256.00
Free Cash Flow
34,393.70
31,386.00
18,069.00
7,913.00
7,719.00
Deferred Taxes & Investment Tax Credit
0.00
0.00
0.00
0.00
0.00
Net Assets from Acquisitions
0.00
0.00
0.00
0.00
0.00
Other Sources
0.00
0.00
0.00
0.00
0.00
Change in Capital Stock
1,493.50
39,728.00
16.00
3.00
0.00
Other Uses
0.00
0.00
0.00
0.00
0.00
Miscellaneous Funds
0.00
0.00
0.00
0.00
0.00
Extraordinaries
0.00
-
0.00
0.00
0.00
About Insys Therapeutics
View Profile
